Blog
RSS FeedPosted by Michael Wonder on 13 Apr 2021
Qilian International announces inclusion of 16 products into China's National Reimbursement Drugs List
13 April 2021 - Qilian International today announced that 16 of its products have been included in the latest version of ...
Posted by Michael Wonder on 12 Apr 2021
Lilly modified COVID-19 purchase agreement for bamlanivimab alone with the U.S. Government and is focusing on supply of bamlanivimab and etesevimab together
12 April 2021 - Eli Lilly today announced changes to the purchase agreements with the U.S. government for its neutralizing antibody ...
Posted by Michael Wonder on 08 Apr 2021
PHARMAC funding to support access equity research
8 April 2021 - PHARMAC Te Pātaka Whaioranga is proud to support Ngā Kaitiaki o Te Puna Rongoā o Aotearoa, ...
Posted by Michael Wonder on 08 Apr 2021
Grant Robertson says Government focused on PHARMAC solution to cancer treatment
8 April 2021 - A woman who has had cancer says heartbreak has turned to anger at the way she ...
Posted by Michael Wonder on 17 Mar 2021
Mythbusting PHARMAC
17 March 2021 - The agency is seeking to dispel some misunderstandings about what it does and how it does ...
Posted by Michael Wonder on 16 Mar 2021
The PHARMAC compromise
17 March 2021 - One thing everybody involved with the inquest into the deaths of six epilepsy patients can agree on ...
Posted by Michael Wonder on 15 Mar 2021
Biden-Harris Administration increases Medicare payment for life saving COVID-19 vaccine
15 March 2021 - Today, the Centers for Medicare & Medicaid Services is increasing the Medicare payment amount for administering the ...
Posted by Michael Wonder on 14 Mar 2021
Over $1.1 billion to extend Australia’s COVID-19 health response
14 March 2021 - The Government will invest more than $1.1 billion to extend our successful national COVID-19 health response ...
Posted by Michael Wonder on 22 Feb 2021
Proposal leaves surgeons bound by private health
23 February 2021 - Australians paying thousands of dollars a year in health insurance could have their access to life-changing ...
Posted by Michael Wonder on 22 Dec 2020
Shionogi’s novel antibiotic, Fetcroja (cefiderocol), has been selected by UK’S NICE/NHSE&I as part of an antimicrobial subscription style reimbursement model
21 December 2020 - NICE and the National Health Service England and Improvement have recognised the potential of Shionogi’s innovative ...
Posted by Michael Wonder on 14 Dec 2020
Diabetes drugs delay shows problem with PHARMAC’s funding model, doctor claims
14 December 2020 - Pharmac’s decision to delay funding approval for two new diabetes drugs has highlighted the shortcomings of ...
Posted by Michael Wonder on 10 Nov 2020
PHARMAC to fund new haemophilia medicine
11 November 2020 - From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people ...
Posted by Michael Wonder on 04 Nov 2020
Update on proposal to fund two new medicines for type 2 diabetes mellitus
5 November 2020 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund two new medicines, ...
Posted by Michael Wonder on 03 Nov 2020
PHARMAC funding resources to focus on medicines access equity
3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...
Posted by Michael Wonder on 22 Oct 2020
Budget is why PHARMAC is letting down New Zealanders, CEO says
22 October 2020 - PHARMAC is struggling to cater to the demand of Kiwis. ...